货号：UP112349320
| 产品信息 | |
| 产品名称： | BMS-794833 |
| 中文名称： | BMS-794833(请以英文为准,中文仅做参考) |
| CAS号： | 1174046-72-0 |
| 分子式： | C23H15ClF2N4O3 |
| 分子量： | 468.84 |
| MDL NO： | MFCD18206786 |
| 标准纯度： | 98+% (UP112349320) |
| 沸点： | 637.2±55.0°C at 760 mmHg |
| 储存： | Keep in dark place,Inert atmosphere,2-8°C (UP112349320) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
抑制剂/受体激动剂
蛋白酪氨酸激酶/受体酪氨酸激酶
DDR1/DDR2 Receptor
抑制剂/受体激动剂
蛋白酪氨酸激酶/受体酪氨酸激酶
c-Kit
抑制剂/受体激动剂
蛋白酪氨酸激酶/受体酪氨酸激酶
双特异性酪氨酸磷酸化调节激酶
Omeprazole metabolite Omeprazole sulfone
UP11619985288546-55-8
CYM 5541
UP291076450945128-26-7
K145 free
UP5996138251309444-75-4
Artepillin C
UP32120757772944-19-5
(4S,5R)-3-(tert-Butoxycarbonyl)-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid
UP542531108196404-55-4
ABC294640
UP150786594915385-81-8
MGCD-265
UP584400107875337-44-3
ZLN024
UP139138467723249-01-2
Chlorthal-dimethyl
UP1504508451861-32-1
Sugammadex sodium
UP650656118343306-79-6
Savolitinib
UP7469594211313725-88-0
2-Methylcyclohexane-1,3-dione
UP5161259751193-55-1
Ademetionine Disulfate Tosylate
UP89427070797540-22-2
PF-543
UP5766996551415562-82-1
(2,2-Bipyridine)bis[2-(2,4-difluorophenyl)pyridine]iridium(III) Hexafluorophosphate
UP8170131404864163-80-4
Sennoside B
UP574269668128-57-4
Risperidone
UP718712226106266-06-2
Foretinib
UP784215911849217-64-7
Pifithrin-α hydrobromide
UP58121045763208-82-2
M1 receptor modulator
UP3900843941227923-29-6
Toceranib
UP402132579356068-94-5
Tenovin-3
UP5290318541011301-27-1
Birinapant
UP8725194201260251-31-7
Tenoxicam
UP18697311659804-37-4
SM-164
UP749196641957135-43-2
Bisacodyl
UP754210914603-50-9
Cevimeline
UP753918966107233-08-9
WZ4003
UP9469669591214265-58-3
5-(4-Bromophenyl)cyclohexane-1,3-dione
UP754372356239132-48-0
c-Met inhibitor 1
UP9691630351357072-61-7
AT-IAP
UP6249326751403898-55-4
LSN 2463359
UP4119921221401031-52-4
tert-Butyl (5-chloro-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate
UP8917719431269440-69-8
KRIBB11
UP891287497342639-96-7
SU14813 maleate
UP189118137849643-15-8
4,4,4-Trifluoro-1-(naphthalen-2-yl)butane-1,3-dione
UP679429273893-33-4
Tivantinib
UP784927113905854-02-6
SU14813(Random Configuration)
UP378466392627908-92-3
2-Hydroxy-5-methylpyridine
UP8530395971003-68-5
NSC 319726
UP28209441371555-25-4
L-Thyroxine sodium
UP28729845455-03-8
11-A-Hydroxy canrenone methyl ester
UP441131753192704-56-6
Tenovin 1
UP142356969380315-80-0
1-Hydroxypyrrolidine-2,5-dione
UP9304446946066-82-6
PF-543 Citrate
UP3808949251415562-83-2
SU6656
UP938726811330161-87-0
1,5-Dibromopentane
UP847977798111-24-0
Methyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate
UP384390616494799-19-8
CP-31398 Dihydrochloride
UP8735755361217195-61-3
1,4-Dichlorobenzene
UP848256044106-46-7
CUDC-427
UP4386975501446182-94-0
Atracurium besylate
UP19838960664228-81-5
Dorsomorphin dihydrochloride
UP4652499491219168-18-9
Ethyl 4-(4-hydroxyphenyl)butanoate
UP67281188862889-58-1
Toceranib phosphate
UP522589117874819-74-6
EMD 1214063
UP6677965281100598-32-0
Pifithrin-β
UP27216694360477-34-1
AC710
UP3119440641351522-04-7
AICAR
UP8709446272627-69-2
Tenovin-6
UP9289834851011557-82-6
Ondansetron
UP20290200499614-02-5
Xanthoplanine
UP5328002926872-88-4
PHenformin hydrochloride
UP134908117834-28-6
Adenosine
UP49824635758-61-7
BMS-794833
UP1123493201174046-72-0